# STELLAR (NCT03899337)

> A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome

No report yet. It can be ordered.

- Drugs tested: acalabrutinib
- Indication: Richter's syndrome

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03899337
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: University of Birmingham
- Conditions: Richter Syndrome
- Interventions: Acalabrutinib; Cyclophosphamide; Doxorubicin; Vincristine; Prednisolone; Rituximab
- Enrollment: 72
- Primary outcome: Randomised Component - Progression free survival (PFS)
- Primary outcome: Registration Arm - Cohort 1 - Overall Response
- Primary outcome: Registration Arm - Cohort 2 - Overall Response

## Indexed commentary on STELLAR so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=stellar-nct03899337